https://scholars.lib.ntu.edu.tw/handle/123456789/471153
Title: | Value of circulating adhesion molecules in assessing cardiac allograft vasculopathy | Authors: | YEN-WEN WU CHII-MING LEE Lee Y.-T. SHOEI-SHEN WANG Huang P.-J. |
Issue Date: | 2003 | Publisher: | Elsevier Inc. | Journal Volume: | 22 | Journal Issue: | 11 | Start page/Pages: | 1284-1287 | Source: | Journal of Heart and Lung Transplantation | Abstract: | Circulating adhesion molecules have been implicated in the development of spontaneous and transplant coronary artery disease. We analyzed soluble (s) intercellular adhesion molecule 1 (sICAM-1), vascular cell adhesion molecule 1 (sVCAM-1), and sE-selectin levels from the coronary sinuses of 25 cardiac allograft recipients, and we correlated these molecules with the degree of acute rejection detected in endomyocardial biopsy specimens and the presence of transplant vasculopathy assessed with coronary angiography. We found that sVCAM-1 significantly increased in patients with transplant vasculopathy compared with those without transplant vasculopathy, whereas sE-selectin and sICAM-1 did not. Therefore, increased coronary sinus levels of sVCAM-1 is a reliable marker in assessing cardiac transplant vasculopathy. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0142154057&doi=10.1016%2fS1053-2498%2803%2900022-6&partnerID=40&md5=bc19bdae7f2f937639e0a26db9f070e9 https://scholars.lib.ntu.edu.tw/handle/123456789/471153 |
ISSN: | 1053-2498 | DOI: | 10.1016/S1053-2498(03)00022-6 | SDG/Keyword: | biological marker; endothelial leukocyte adhesion molecule 1; intercellular adhesion molecule 1; vascular cell adhesion molecule 1; acute graft rejection; adult; article; clinical article; controlled study; coronary sinus; correlation analysis; female; follow up; heart muscle biopsy; heart transplantation; human; human tissue; male; priority journal; protein blood level; protein localization; statistical significance; tissue distribution |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.